Decellularized Extracellular Matrix Materials for Cardiac Repair and Regeneration.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30714354.
- Also identified by DOI 10.1002/adhm.201801217 and PMC identifier 7654553.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Decellularized extracellular matrix (dECM) is a promising biomaterial for repairing cardiovascular tissue, as dECM most effectively captures the complex array of proteins, glycosaminoglycans, proteoglycans, and many other matrix components that are found in native tissue, providing ideal cues for regeneration and repair of damaged myocardium. dECM can be used in a variety of forms, such as solid scaffolds that maintain native matrix structure, or as soluble materials that can form injectable hydrogels for tissue repair. dECM has found recent success in many regeneration and repair therapies, such as for musculoskeletal, neural, and liver tissues. This review focuses on dECM in the context of cardiovascular applications, with variations in tissue and species sourcing, and specifically discusses advances in solid and soluble dECM development, in vitro studies, in vivo implementation, and clinical translation.
Medical subject headings
- Biocompatible Materials
- Cardiovascular System
- Extracellular Matrix
- Regeneration
- Tissue Scaffolds